deltatrials
Recruiting EARLY_PHASE1 INTERVENTIONAL 1-arm NCT06664151

A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision

Sponsor: Dana-Farber Cancer Institute

Conditions Cutaneous Squamous Cell Cancer Cutaneous Squamous Cell Carcinoma (CSCC) Skin Cancer
Interventions Fluzone Trivalent
Updated 4 times since 2024 Last updated: Oct 1, 2025 Started: Nov 26, 2024 Primary completion: Aug 30, 2026 Completion: Aug 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06664151, this EARLY_PHASE1 trial focuses on Cutaneous Squamous Cell Cancer and Cutaneous Squamous Cell Carcinoma (CSCC) and remains actively recruiting participants. Sponsored by Dana-Farber Cancer Institute, it has been updated 4 times since 2024, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Nov 2024 – ~Dec 2024 · 30 days · monthly snapshot~Dec 2024 – ~Feb 2025 · 2 months · monthly snapshotRecruiting~Feb 2025 – ~Nov 2025 · 9 months · monthly snapshotRecruiting~Nov 2025 – present · 9 months · monthly snapshotRecruiting

Change History

4 versions recorded

  1. Nov 2025 — Present [monthly]

    Recruiting EARLY_PHASE1

  2. Feb 2025 — Nov 2025 [monthly]

    Recruiting EARLY_PHASE1

  3. Dec 2024 — Feb 2025 [monthly]

    Recruiting EARLY_PHASE1

    Status: Not Yet Recruiting → Recruiting

  4. Nov 2024 — Dec 2024 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dana-Farber Cancer Institute
Data source: Dana-Farber Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations